Literature DB >> 9757913

Tumor necrosis factor locus: genetic organisation and biological implications.

N J Makhatadze1.   

Abstract

TNF genes determine strength, effectiveness, and duration of local and systemic inflammatory reactions, as well as repair and recovery from infectious and toxic agents. Multiple pro- and anti-inflammatory activities of TNF factors are conditioned by their profound effects on metabolism of many cell types, their activation state, cell survival and others. TNF genes show strong linkage disequilibrium with HLA class I and class II genes and with other genes in the MHC region relevant to immuneregulation. Structural or regulatory defects in TNF genes may contribute to pathogenesis of MHC associated diseases especially those with inflammatory and autoimmune components.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757913     DOI: 10.1016/s0198-8859(98)00056-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  20 in total

1.  IL-1ra anti-inflammatory cytokine polymorphism is associated with risk of gastric cancer and chronic gastritis in a Brazilian population, but the TNF-β pro-inflammatory cytokine is not.

Authors:  J Garcia Oliveira; M Cristina Duarte; A Elizabete Silva
Journal:  Mol Biol Rep       Date:  2012-02-12       Impact factor: 2.316

2.  3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.

Authors:  Isabella Russo; Luca Caracciolo; David Tweedie; Sang-Ho Choi; Nigel H Greig; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2012-07-25       Impact factor: 5.372

Review 3.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

4.  Biomechanical strain regulates TNFR2 but not TNFR1 in TMJ cells.

Authors:  James Deschner; Birgit Rath-Deschner; Ewa Wypasek; Mirela Anghelina; Danen Sjostrom; Sudha Agarwal
Journal:  J Biomech       Date:  2006-10-16       Impact factor: 2.712

5.  Tumor necrosis factor alpha -238 G/A and -308 G/A polymorphisms and soluble TNF-α levels in chronic kidney disease: correlation with clinical variables.

Authors:  Diana I Vázquez-Huerta; Bertha A Alvarez-Rodríguez; Jorge F Topete-Reyes; José F Muñoz-Valle; Renato Parra-Michel; Francisco Fuentes-Ramírez; María A Salazar-López; Yeminia Valle; Zyanya Reyes-Castillo; A Cruz-González; Lorena M Brennan-Bourdon; Norma Torres-Carrillo
Journal:  Int J Clin Exp Med       Date:  2014-08-15

6.  Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome.

Authors:  Omer Ateş; Levent Dalyan; Gulen Hatemi; Vedat Hamuryudan; Aysegul Topal-Sarıkaya
Journal:  Mol Biol Rep       Date:  2010-02-27       Impact factor: 2.316

7.  Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymorphism and gene expression).

Authors:  Ahmad A Al Robaee
Journal:  Int J Health Sci (Qassim)       Date:  2010-11

8.  Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; John Farrell; Kathryn L Lunetta; Gyungah Jun; Clinton T Baldwin; Margaret M Deangelis; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

9.  Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients.

Authors:  Omer Ates; Gulen Hatemi; Vedat Hamuryudan; Aysegul Topal-Sarikaya
Journal:  Clin Rheumatol       Date:  2008-04-22       Impact factor: 2.980

10.  Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia.

Authors:  Vesna Boraska; Eleftheria Zeggini; Christopher J Groves; Nigel W Rayner; Veselin Skrabić; Mahamadou Diakite; Kirk A Rockett; Dominic Kwiatkowski; Mark I McCarthy; Tatijana Zemunik
Journal:  Hum Immunol       Date:  2009-01-22       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.